- Home
- PEP vs AZN Comparison
PEP vs AZN Comparison
Compare PEP & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEP
- AZN
- Stock Information
- Founded
- PEP 1898
- AZN 1992
- Country
- PEP United States
- AZN United Kingdom
- Employees
- PEP N/A
- AZN N/A
- Industry
- PEP Beverages (Production/Distribution)
- AZN Biotechnology: Pharmaceutical Preparations
- Sector
- PEP Consumer Staples
- AZN Health Care
- Exchange
- PEP Nasdaq
- AZN Nasdaq
- Market Cap
- PEP 204.8B
- AZN 237.5B
- IPO Year
- PEP N/A
- AZN 1993
- Fundamental
- Price
- PEP $144.61
- AZN $73.30
- Analyst Decision
- PEP Buy
- AZN Strong Buy
- Analyst Count
- PEP 14
- AZN 3
- Target Price
- PEP $156.92
- AZN $95.00
- AVG Volume (30 Days)
- PEP 9.5M
- AZN 5.3M
- Earning Date
- PEP 07-17-2025
- AZN 07-29-2025
- Dividend Yield
- PEP 3.95%
- AZN 2.06%
- EPS Growth
- PEP N/A
- AZN 28.86
- EPS
- PEP 5.49
- AZN 5.31
- Revenue
- PEP $91,748,000,000.00
- AZN $56,501,000,000.00
- Revenue This Year
- PEP $2.38
- AZN $9.80
- Revenue Next Year
- PEP $3.11
- AZN $6.26
- P/E Ratio
- PEP $26.21
- AZN $14.05
- Revenue Growth
- PEP N/A
- AZN 15.00
- 52 Week Low
- PEP $127.60
- AZN $61.24
- 52 Week High
- PEP $179.73
- AZN $87.68
- Technical
- Relative Strength Index (RSI)
- PEP 60.83
- AZN 52.92
- Support Level
- PEP $137.64
- AZN $73.42
- Resistance Level
- PEP $144.40
- AZN $75.10
- Average True Range (ATR)
- PEP 2.40
- AZN 1.29
- MACD
- PEP -0.17
- AZN 0.11
- Stochastic Oscillator
- PEP 73.32
- AZN 54.58
About PEP PepsiCo Inc.
PepsiCo is a global leader in snacks and beverages, owning well-known household brands including Pepsi, Mountain Dew, Gatorade, Lay's, Cheetos, and Doritos, among others. The company dominates the global savory snacks market and also ranks as the second-largest beverage provider in the world (behind Coca-Cola) with diversified exposure to carbonated soft drinks, or CSD, as well as water, sports, and energy drink offerings. Convenience foods account for approximately 55% of its total revenue, with beverages making up the rest. Pepsi owns the bulk of its manufacturing and distribution capacity in the US and overseas. International markets make up 40% of total sales and one third of operating profits.
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.